Phenomenex expands Kinetex F5 (Pentafluorophenyl) HPLC/UHPLC Core-Shell Line to 5 µm for Preparative LC Read more
‘Over next three to five years, we intend to expand the existing capacities of large and small volume parenterals to meet the expanding demand’ Read more
Strict or stringent national regulatory authority for procurement of anti-tuberculosis medicines? Read more
Global cancer supportive care therapeutics market to see negligible growth to $12.4 billion by 2022 Read more
‘We have to create an ecosystem where companies are encouraged to constantly pursue next generation products’ Read more